Anandwardhan A Hardikar
Overview
Explore the profile of Anandwardhan A Hardikar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1847
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hardikar A, Bhonde R, Umrani M, Joglekar M
Nature
. 2025 Mar;
639(8054):306.
PMID: 40069416
No abstract available.
2.
Chan R, Huang C, Ng N, Tam H, Tam C, Cheng F, et al.
Endocrinol Diabetes Metab
. 2025 Feb;
8(2):e70030.
PMID: 39963020
Background: Polycystic ovary syndrome (PCOS) is one of the commonest gyneco-endocrine disorders amongst women of reproductive age. Whether PCOS and cardiometabolic traits in PCOS patients are associated with shortened telomere...
3.
Polkamp M, Pham N, Wong W, Hardikar H, Kunte P, Cameron M, et al.
BMC Med
. 2025 Feb;
23(1):84.
PMID: 39939938
Background: Early identification and management of sight-threatening ocular complications of diabetes using imaging or molecular biomarkers could help prevent vision loss. However, access to specialized infrastructure and expertise is limited,...
4.
Joglekar M, Kaur S, Pociot F, Hardikar A
Lancet Diabetes Endocrinol
. 2024 May;
12(7):483-492.
PMID: 38797187
Identifying biomarkers of functional β-cell loss is an important step in the risk stratification of type 1 diabetes. Genetic risk scores (GRS), generated by profiling an array of single nucleotide...
5.
Shihana F, Joglekar M, Schwantes-An T, Hardikar A, Seth D
Biology (Basel)
. 2023 Oct;
12(10).
PMID: 37887024
Alcohol-associated liver disease (ALD) is the most common disorder of prolonged drinking. Mechanisms underlying cirrhosis in such patients remain unclear. MicroRNAs play regulatory role in several diseases, are affected by...
6.
Wong W, Polkamp M, Farr R, Kunte P, Hardikar H, Yajnik C, et al.
Methods Mol Biol
. 2023 Jun;
2678:117-134.
PMID: 37326708
Diabetic retinopathy (DR) is a vascular complication of diabetes that can lead to partial or complete loss of vision. Early detection and treatment of DR can prevent blindness. Regular clinical...
7.
Pham N, Joglekar M, Wong W, Nassif N, Simpson A, Hardikar A
Nutr Rev
. 2023 Jun;
82(2):193-209.
PMID: 37290429
Context: There is substantial evidence that reduced short-chain fatty acids (SCFAs) in the gut are associated with obesity and type 2 diabetes, although findings from clinical interventions that can increase...
8.
ORourke M, Januszewski A, Sullivan D, Lengyel I, Stewart A, Arya S, et al.
Proteomics Clin Appl
. 2023 Mar;
17(3):e2200106.
PMID: 36891577
Purpose: Robust, affordable plasma proteomic biomarker workflows are needed for large-scale clinical studies. We evaluated aspects of sample preparation to allow liquid chromatography-mass spectrometry (LC-MS) analysis of more than 1500...
9.
Daas S, Ahmed I, Hasan W, Abdelrahman D, Aliyev E, Nisar S, et al.
J Transl Med
. 2023 Mar;
21(1):171.
PMID: 36869348
Background: Type 2 diabetes (T2D) is a critical healthcare challenge and priority in Qatar which is listed amongst the top 10 countries in the world, with its prevalence presently at...
10.
Wong K, Cheng F, Lim C, Tam C, Tutino G, Yuen L, et al.
BMC Med
. 2022 Dec;
20(1):490.
PMID: 36536359
Background: Leukocyte telomere length (LTL) is suggested to be a biomarker of biological age and reported to be associated with metabolic diseases such as type 2 diabetes. Glucose metabolic traits...